readthroughSign in
CompanyIOVANasdaqSan Carlos, CA

Iovance Biotherapeutics, Inc.

Iovance develops tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors.

424B3Nov 12Latest SEC filing
Nov 9Latest story